Gene entry
CACNA1A
calcium voltage-gated channel subunit alpha1 A
- Chromosome
- 19
- Cytoband
- 19p13.13
- Variants (rsID)
- 121
CACNA1A is a protein-coding gene, meaning the body reads it as instructions to build a protein, located on chromosome 19 (region 19p13.13). Its official name is “calcium voltage-gated channel subunit alpha1 A”. The reference table lists 121 variants (rsID) for this gene.
Clinically classified variants
27 reference-table entries with clinical significance.
- rs16016Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs16019Benignsingle nucleotide variantDevelopmental and epileptic encephalopathy, 42|Episodic ataxia type 2|History of neurodevelopmental disorder
- rs16022Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2
- rs16023Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2
- rs16030Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs199793367Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs201612257Benignsingle nucleotide variantEpisodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs2248069Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2|Migraine, familial hemiplegic, 1|Spinocerebellar ataxia type 6
- rs41276886Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2
- rs749357610Benignsingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs121908242Conflicting interpretationssingle nucleotide variantEpisodic ataxia type 2|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2
- rs121908247Conflicting interpretationssingle nucleotide variantSpinocerebellar ataxia type 6|Chronic and progressive ataxia|Enlarged cisterna magna|Global developmental delay|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2|History of neurodevelopmental disorder|Ataxia _ Neurologic (child onset)|Non-progressive congenital cerebellar ataxia|Neurodevelopmental delay
- rs16024Conflicting interpretationssingle nucleotide variantInborn genetic diseases|Developmental and epileptic encephalopathy, 42|History of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42|Intellectual disability
- rs184723350Conflicting interpretationssingle nucleotide variantEpisodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs187393245Conflicting interpretationssingle nucleotide variantEpisodic ataxia type 2|Developmental and epileptic encephalopathy, 42|History of neurodevelopmental disorder
- rs199886234Conflicting interpretationssingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs201200430Conflicting interpretationssingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs374307014Conflicting interpretationssingle nucleotide variantHistory of neurodevelopmental disorder|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2
- rs374749004Conflicting interpretationssingle nucleotide variantDevelopmental and epileptic encephalopathy, 42|Episodic ataxia type 2
- rs375628894Conflicting interpretationssingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs751675055Conflicting interpretationssingle nucleotide variantEpisodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs756972061Conflicting interpretationssingle nucleotide variantEpisodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs757291476Conflicting interpretationssingle nucleotide variantHistory of neurodevelopmental disorder|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs121908228Likely pathogenicsingle nucleotide variantEpisodic ataxia type 2|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42
- rs121908220Pathogenicsingle nucleotide variantMigraine, familial hemiplegic, 1
- rs794727411Pathogenicsingle nucleotide variantEpisodic ataxia type 2|Migraine, familial hemiplegic, 1|Developmental and epileptic encephalopathy, 42|Inborn genetic diseases|Spinocerebellar ataxia type 6|Migraine|Migraine, familial hemiplegic, 1|Episodic ataxia type 2|Episodic ataxia type 2|Developmental and epileptic encephalopathy, 42|Episodic ataxia type 2|Spinocerebellar ataxia type 6|Migraine, familial hemiplegic, 1|Developmental and epileptic encephalopathy, 52
- rs201789073Uncertain significancesingle nucleotide variantDevelopmental and epileptic encephalopathy, 42|Episodic ataxia type 2
Other listed variants
- rs1345649
- rs1422257
- rs1547986
- rs2074880
- rs2112460
- rs2292035
- rs2419549
- rs2900964
- rs4244619
- rs4340440
- rs4499352
- rs4632265
- rs4926152
- rs4926159
- rs4926244
- rs4926265
- rs4926275
- rs4926293
- rs7250783
- rs7250857
- rs7251951
- rs7252316
- rs7254351
- rs7254771
- rs7259944
- rs8101888
- rs8104916
- rs8105564
- rs8109003
- rs8113506
- rs10403191
- rs10407144
- rs10412211
- rs10414649
- rs10416717
- rs10422305
- rs10424916
- rs10425612
- rs11085841
- rs11085844
- rs11666986
- rs11672268
- rs11878882
- rs11879128
- rs11881823
- rs12151262
- rs12462609
- rs12610465
- rs12610699
- rs12611029
- rs12972559
- rs12974636
- rs12977265
Public references
Data from the institutional reference table and public NCBI annotation. For education only; not a substitute for medical or genetic counselling.
